Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis

PURPOSE: An update of a systematic review and meta-analysis of the risk of arrhythmias and their subtypes in type 2 diabetic patients receiving glucagon-like peptide 1 receptor agonist (GLP-1RA) medication according to data from the Cardiovascular Outcome Trial(CVOT). METHODS: Randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jinjing, Wang, Ruxin, Ye, Haowen, Wang, Ying, Wang, Lihong, Zhang, Xiaofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403613/
https://www.ncbi.nlm.nih.gov/pubmed/36034440
http://dx.doi.org/10.3389/fendo.2022.910256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403613/
https://www.ncbi.nlm.nih.gov/pubmed/36034440
http://dx.doi.org/10.3389/fendo.2022.910256

Ejemplares similares